Basic Requirements for Blood Donation• Must be at least 18 years of age or 16 or 17 with written parental or guardian consent.
• Weigh at least 110 pounds; if greater than 350 pounds, please call Bonfils’ Appointment Center at 303.363.2300 or 800.365.0006, opt. 2.
• Please drink plenty of fluids throughout the day and eat a healthy low-fat meal four hours prior to your donation.
• Be in good general health.
• The donation interval after a whole blood donation is 56 days. Please contact Bonfils Blood Center for the specific interval for other • Please call Bonfils’ Donor Relations department at 303.363.2202 or 800.365.0006, opt. 1 for complete information on donor eligibility. For general information call Bonfils’ 24-hour information lines at 303.366.2000 or 800.365.0006.
Health Conditions
Ambulatory Aid: For their own safety, donors using any type
Hepatitis/Hepatitis Exposure:
of temporary ambulatory aids including crutches, canes or other • Donor is deferred with a history of hepatitis at age 11 or older walking aids for a recent injury cannot donate until no longer • Donor is deferred for 12 months following hepatitis A, B requiring this assistance. Donors using permanent ambulatory aid may be pre-approved to donate by contacting Bonfils’ Donor Relations department at 303.363.2202 or 800.365.0006, opt. 1. • Hepatitis secondary to a disease process is acceptable Unfortunately, mobile bus programs are unable to accommodate • High Blood Pressure: Donors with high blood pressure
are eligible to donate if their blood pressure is within an • Breastfeeding: Female donors that are breastfeeding are eligible
acceptable range when taken on the day of donation, • Cancer: Donor is eligible with a history of basal cell or squamous
Malaria: Donor is eligible if symptom free for three years.
cell skin cancer or carcinoma in situ (type/size). All other forms • Pregnant: Pregnant donors are not eligible to donate.
of cancer will be assessed at time of donation. Lymphoma and leukemia are currently permanent deferrals.
Transfusion: Donor is deferred for 12 months after a
transfusion of blood or blood products.
Colds: Donors are not eligible if they are not feeling well and
Diabetes: Donors with diabetes (type I or II) are eligible to
Individuals who have had a positive test for HIV/AIDS or who are donate. Diabetics who ever used bovine insulin manufactured in at risk for contracting HIV/AIDS are permanently deferred from • Heart Disease: Donors with a history of heart disease or
• Use of illegal, street drugs or steroids not prescribed by a heart attacks may be eligible to donate provided six months have elapsed from the incident and approval has been obtained from • Ongoing treatment with clotting factor concentrates for your physician. For additional details, contact Donor Relations hemophilia or similar blood clotting disorders department at 303.363.2202 or 800.365.0006, opt. 1 for eligibility requirements.
• Taking money or drugs for sex since 1977 • Hemochromatosis/Polycythemia: Donors diagnosed with
• Male to male sexual contact, even once, since 1977 hereditary hemochromatosis or polycythemia are asked to contact Bonfils’ Donor Relations department at 303.363.2202 or 800.365.0006, opt. 1 to learn more about donation options.
The following risk factors represent a 12-month deferral for the • Tattoos/Permanent Make-up: Donor is eligible if tattooing/
• Intimate/sexual contact with any person in the above categories make-up application is performed in a physician’s office using • Accidental contact with another person’s blood/body fluid or an single use equipment. Otherwise, donor is deferred for • Ear/Body Piercing: Donor is eligible if piercing was performed
• Incarceration for more than 72 consecutive hours using single use equipment. Otherwise, donor is deferred for 12 months. Note: Piercing done at Claire’s stores and similar establishments
When the drugs listed in this section are taken for a specific medical condition, donors should not discontinue taking drugs prescribed or recommended by their physicians in order to be eligible to donate. If you are currently using or have ever used, • Donor is deferred for 12 months after travel to a malarial- any of the following medications, please contact Bonfils’ Donor Relations department at 303.363.2202 or 800.365.0006, • Donor is deferred for three years after departure from a opt. 1 to determine your eligibility.
malarial-endemic area if he/she is an immigrant, refugee, citizen • Accutane (Amnesteem, Claravis, Sotret, isotretinoin) –
or resident of the area. Residents are defined as having lived in an • Antibiotics – given for an active infection
vCJD Variant Creutzfeld-Jakob Disease (human form of
Note: Antibiotics given for prophylactic use are acceptable.
mad cow disease)
Avodart (dutasteride) – usually given for prostate enlargement
• Donor is deferred for travel/residence of three months or more • Coumadin (warfarin, Warfilone) – usually given for blood clots
in the United Kingdom from 1980-1996.
• Blood donor tests may not be available for some contagious • Growth Hormone from Human Pituitary Glands
diseases that are found only in certain countries. If you were used only until 1985, usually for children with delayed or born in, lived in or visited certain countries, you may not be Countries in United Kingdom:
Hepatitis B Immune Globulin – given following an exposure
Note: This is different from the hepatitis B vaccine which is
a series of three injections given over a six-month period to prevent future infection from exposures to hepatitis.
European Countries:
Jalyn (dutasteride/tamsulosin) – usually given for prostate
Propecia (finasteride) – usually given for baldness
Proscar (finasteride) – usually given for prostate
Soriatane (acitretin) – usually given for severe psoriasis
Tegison (etretinate) – usually given for severe psoriasis
• Extended periods of time in Europe may be a reason for deferral, however donors should speak with a Bonfils representative before they decide not to donate blood. Each case will be assessed at the time of donation or by calling Bonfils’ Donor Relations department at 303.363.2202 or 800.365.0006, opt. 1.



Sicherheitsdatenblatt gemäß Verordnung (EG) 1907/2006 Handelsname : Überarbeitet am : Version (Überarbeitung) : Druckdatum : 1. Bezeichnung des Stoffs bzw. des Gemischs und des Unternehmens 1.1 Produktidentifikator 1.2 Relevante identifizierte Verwendungen des Stoffs oder Gemischs Verwendungen, von denen abgeraten wird 1.3 Einzelheiten


Robert J. Ziets, MD, FAAOS Orthopaedic Surgery Certified, American Board of Orthopaedic Surgery Fellow, American Academy of Orthopaedic Surgeons Assistant Professor of Orthopaedic Surgery, Albert Einstein College of MedicineAttending Physician, Departments of Orthopaedic Surgery, Beth Israel Medical Center & St. Luke's-Roosevelt Hospital Center 910 Park Avenue, New York, New York 100

© 2008-2018 Medical News